9 Einträge gefunden

1. Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16

   1. Lennartz, Maximilian
   2. Csomós, Henrietta
   3. Bernreuther, Christian
   4. Büscheck, Franziska
   5. Fraune, Christoph
   6. Simon, Ronald
   7. Sauter, Guido

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence

   1. Dum, David
   2. Henke, Tjark L C
   3. Mandelkow, Tim
   4. Yang, Cheng
   5. Bady, Elena
   6. Raedler, Jonas B
   7. Simon, Ronald

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer

   1. Marx, Andreas
   2. Koopmann, Lena
   3. Höflmayer, Doris
   4. Büscheck, Franziska
   5. Hube-Magg, Claudia
   6. Steurer, Stefan
   7. Eichenauer, Till

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
5. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
6. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
7. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

   1. Steurer, Stefan
   2. Schwemmer, Lara
   3. Hube-Magg, Claudia
   4. Büscheck, Franziska
   5. Höflmayer, Doris
   6. Tsourlakis, Maria Christina
   7. Clauditz, Till S

   2019 - Forschungsinformationssystem des UKE
8. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
9. CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.

   1. Nienstedt, Julie Cläre
   2. Gröbe, Alexander
   3. Lebok, Patrick
   4. Büscheck, Franziska
   5. Clauditz, Till Sebastian
   6. Simon, Ronald
   7. Heumann, Asmus

   2017 - Forschungsinformationssystem des UKE